Sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and myocardial infarction undergoing percutaneous coronary intervention: A systematic review and meta-analysis☆. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.